Ex-Pharma Exec Hit With $5.3M Fee Award In Del.
The Delaware Chancery Court has ordered a former pharmaceutical executive to pay more than $5.3 million in attorney fees following years of litigation over alleged disloyal conduct and trade secret misuse,...To view the full article, register now.
Already a subscriber? Click here to view full article